L F Fries
Overview
Explore the profile of L F Fries including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
921
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fries L, Montemarano A, Mallett C, Taylor D, Hale T, Lowell G
Infect Immun
. 2001 Jun;
69(7):4545-53.
PMID: 11401998
We studied the safety and immunogenicity of a Shigella flexneri 2a vaccine comprising native S. flexneri 2a lipopolysaccharide (LPS) complexed to meningococcal outer membrane proteins-proteosomes-in normal, healthy adults. A two-dose...
2.
Fries L, Tartaglia J, Taylor J, Kauffman E, Meignier B, Paoletti E, et al.
Vaccine
. 1996 Apr;
14(5):428-34.
PMID: 8735555
Avian poxvirus recombinants undergo abortive replication in nonavian cells, yet can achieve expression of extrinsic gene products. Canarypox-vectored vaccines have been innocuous and immunogenic in several mammalian species. ALVAC-RG, a...
3.
Karron R, Steinhoff M, Subbarao E, Wilson M, MacLeod K, Clements M, et al.
Pediatr Infect Dis J
. 1995 Jan;
14(1):10-6.
PMID: 7715982
A safe and effective influenza vaccine is needed to prevent serious influenza illness in infants younger than 6 months of age. The purpose of this study was to determine whether...
4.
Steinhoff M, Fries L, Karron R, Clements M, Murphy B
J Clin Microbiol
. 1993 Apr;
31(4):836-8.
PMID: 8463393
Resistance to infection with an influenza A virus conferred by previous infection with an influenza A virus belonging to another subtype is called heterosubtypic immunity. Heterosubtypic immunity is demonstrable in...
5.
Fries L, Waag D, Williams J
Infect Immun
. 1993 Apr;
61(4):1251-8.
PMID: 8454328
Current Q fever vaccines, consisting of Formalin-inactivated phase I whole Coxiella burnetii, are highly efficacious in preventing disease in high-risk settings but are associated with a risk of unacceptable local...
6.
Fries L, Dillon S, Hildreth J, Karron R, Funkhouser A, FRIEDMAN C, et al.
J Infect Dis
. 1993 Mar;
167(3):593-601.
PMID: 8440931
A recombinant influenza A vaccine (D protein), comprising a carboxy-terminal sequence from the hemagglutinin HA2 subunit of A/Puerto Rico/8/34 virus (H1N1, A/PR/34) fused to 81 amino-terminal residues of the NS1...
7.
Fries L, Gordon D, Schneider I, Beier J, Long G, Gross M, et al.
Infect Immun
. 1992 May;
60(5):1834-9.
PMID: 1563771
Twenty-one malaria-naive volunteers were immunized with a vaccine consisting of a 22-kDa recombinant peptide (R32LR), derived from the repeat region of Plasmodium falciparum circumsporozoite (CS) protein, covalently coupled to detoxified...
8.
Clements M, Subbarao E, Fries L, Karron R, London W, Murphy B
J Clin Microbiol
. 1992 Mar;
30(3):655-62.
PMID: 1551982
The transfer of six internal RNA segments from the avian influenza A/Mallard/New York/6750/78 (H2N2) virus reproducibly attenuates human influenza A viruses for squirrel monkeys and adult humans. To identify the...
9.
Powers D, Murphy B, Fries L, Adler W, Clements M
J Am Geriatr Soc
. 1992 Feb;
40(2):163-7.
PMID: 1740601
Objective: To compare young and elderly adults in terms of their immune responses and rates of infection following intranasal vaccination with a live attenuated influenza virus. Design: Time series, comparing...
10.
Fries L, Gordon D, Richards R, Egan J, Hollingdale M, Gross M, et al.
Proc Natl Acad Sci U S A
. 1992 Jan;
89(1):358-62.
PMID: 1729706
This study describes the safety and immunogenicity of a liposome-based vaccine injected into human subjects. Thirty healthy adult male volunteers were immunized with a liposome-encapsulated recombinant protein (R32NS181) containing epitopes...